YB-1 has been shown to be overexpressed in tumors of the breast, lung, ovary, colon and prostate [12–16], and such upregulation is highly correlated with tumor progression, invasion, metastasis and angiogenesis [17]. Here, YBX1 is linked to neoplasm.